Navigation Links
Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk
Date:1/31/2009

CINCINNATI, Jan. 31 /PRNewswire-FirstCall/ -- The Kroger Co. (NYSE: KR) said today it is recalling peanut butter store-baked and store-packaged cookies and select cakes sold in its family of stores because the products have the potential to be contaminated with Salmonella.

Stores under the following names in the 31 states where Kroger operates are included in this recall: Kroger, Ralphs, Fred Meyer, Food 4 Less, Fry's, King Soopers, Smith's, Dillons, QFC, City Market, Foods Co., Jay C, Scott's, Owen's, Baker's, Gerbes, Hilander and Pay Less.

No illnesses have been reported in connection with the cookies and cakes.

Item Descriptions:

Kroger is recalling all packages of the following Kroger, Store-Brand and Private Selection store-baked and store-packaged cookies:

  • Peanut Butter Cookies - Regular, Jumbo, Decorated, Iced, Gourmet, Mini and Sandwich cookies
  • Assorted and Variety Bakery Cookies - Regular and Jumbo
  • Private Selection Peanut Chocolate Chunk Cookies
  • Private Selection Gourmet Variety Cookie Trays

Kroger is recalling all sizes of the following Private Selection Cakes, including whole, half and packaged slices:

  • Private Selection Chocolate Trio Single-Layer and Double-Layer Iced Cakes

Customers who have purchased any of the cookies or cakes listed above should not consume these products and should return them to a store for a full refund or replacement.

The products Kroger is recalling may be associated with the peanut product recall by Peanut Corporation of America (PCA). The FDA has indicated that PCA is the focus of its investigation into Salmonella-related illnesses that may be linked to contaminated peanut products. For more information, please visit the FDA's website at www.fda.gov.

Kroger continues to follow FDA guidelines and, for the safety of customers, has withdrawn other products from sale that contain peanut ingredients implicated in this outbreak, as directed by the FDA and suppliers involved.

Salmonella is an organism that can cause serious and sometimes fatal infections, particularly in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain. For more information on Salmonella, please visit the Centers for Disease Control and Prevention's website at www.cdc.gov.

According to the FDA, peanut butter sold in jars, including Kroger brand peanut butter sold in the retailer's family of stores, is not involved in the ongoing investigation.

Customers who have questions about the cookie and cake recall may contact Kroger toll-free at (800) 632-6900. For more information, please visit Kroger's website at www.kroger.com/recalls.

Kroger is notifying customers about this recall by placing signs in stores in bakery departments. Kroger is also activating its register receipt and phone call notification systems to alert customers about recalls of products they may have purchased.

Kroger, one of the nation's largest retail grocery chains, employs more than 320,000 associates who serve customers in 2,477 supermarkets and multi-department stores in 31 states. Kroger operates stores under two dozen local banner names including Kroger, Ralphs, Fred Meyer, Food 4 Less, Fry's, King Soopers, Smith's, Dillons, QFC and City Market. In addition, Kroger associates serve customers in 778 convenience stores, 392 fine jewelry stores and 750 supermarket fuel centers the Company operates. Kroger also operates 41 food processing plants in the U.S. Headquartered in Cincinnati, Ohio, Kroger focuses its charitable efforts on supporting hunger relief, health and wellness initiatives, and local schools and grassroots organizations in the communities it serves. For more information about the Company, please visit www.kroger.com.


'/>"/>
SOURCE The Kroger Co.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment
2. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
3. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
4. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
5. TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients
6. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
7. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
8. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
9. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
10. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
11. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... In ... They celebrate 30 years in business this year, and they’re marking the milestone ... space to serve their patients. , It stands to reason that, given ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... ... Paul Vitenas, MD, FACS , is honored to announce that he ... the nation’s top physicians, in a variety of specialties. This marks the fourth year ... Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of information on ...
Breaking Medicine News(10 mins):